AWARD PURSUANT TO ARTICLE 76, PARAGRAPH 2, LETTER B) OF THE DRUG JAYPIRCA*56CPR RIV 100MG (ACTIVE INGREDIENT PIRTOBRUTINIB)

This tender, issued by ASL Roma 2, pertains to the procurement of the pharmaceutical product JAYPIRCA. The product is available in a 56-capsule, delayed-release formulation with a 100mg dosage. The active ingredient is Pirtobrutinib. This is a supply contract for medicinal products, categorized under 'Medicinali vari' (various medicines). The procurement was conducted via a single-stage other procedure, as per Article 76, paragraph 2, letter b) of the Italian Public Procurement Code. The estimated value for this acquisition was EUR 239,395.20. The contract was awarded to ELI LILLY ITALIA S.P.A. for the full estimated amount of EUR 239,395.20. The procurement took place in Rome, Italy. This award reflects ASL Roma 2's dedication to providing advanced pharmaceutical treatments, likely for oncological or immunological conditions, to its patient population.

This is a supplies contract in the general supplies sector, with a focus on General Supplies. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 239,395.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.